PGY2 Solid Organ Transplant

Residency Purpose Statement

The purpose of the PGY2 Pharmacy Residency is to build on Doctor of Pharmacy (PharmD) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.

Program Overview

Vanderbilt University Medical Center, in conjunction with the Vanderbilt Transplant Center, offers a one-year specialty residency in solid organ transplantation. The Vanderbilt Transplant Center specializes in kidney, liver, pancreas, heart and lung transplantation. The purpose of the residency is to develop a clinical transplant pharmacist competent in all areas of solid organ transplantation and a leader among their peers. The resident is expected to participate in the continuum of care of transplant recipients.

Vanderbilt has a long history of experience in solid organ transplant dating back to 1962. The Vanderbilt Transplant Center grows and reaches new milestones each year. In recent years, Vanderbilt has established its place in the top 10 highest volume transplant centers in the nation, performing 645 transplants in 2021.

In addition to transplant center achievements, each organ group has accomplishments to celebrate. In 2021, the kidney/pancreas transplant program absorbed the VA transplant program and performed a record 315 kidney transplants. The Vanderbilt liver transplant program has recently started a living donor liver transplant program. The Vanderbilt heart transplant program continues to grow annually emerging as the highest volume heart transplant center in the world performing a record of 124 heart transplants in 2021. Ten transplant pharmacists support the Vanderbilt Transplant Center providing exceptional pharmaceutical care to transplant patients across all organ groups including in pediatrics.

Rotations

Core

Elective*

Renal/Pancreas Transplant (8 weeks)

Pediatric Transplant

Liver Transplant (8 weeks)

Mechanical Cardiac Support (2 weeks)

Inpatient Heart Transplant (6-8 weeks)

Hepatology

Inpatient Lung Transplant (4-6 weeks)

Critical Care (CVICU or SICU)

Cardiothoracic Transplant Clinic (4 weeks)

Repeat of any previous Transplant organ experience

Transplant Infectious Diseases (4 weeks)

 

* other options may be available

Longitudinal Experiences

  • Research Project
  • Continuing Education Presentation
  • Quality Improvement Project or Medication Use Evaluation
  • Case Conference Presentation
  • Layered Learning Transplant Topic Discussions
  • VUMC Residence Professional Development Series
  • Pharmacy Newsletter Article

Additional Opportunities

  • Distinction in Transplant Administration Program (optional)
  • Attendance at Annual Vanderbilt Transplant Nurse Practitioner Symposium
  • HLA Lab Introduction and Visitation
  • AST Fellows Symposium

How to Apply

Applicant must be a graduate of an accredited B.S. or Doctor of Pharmacy program, be a licensed pharmacist in any state with reciprocation to Tennessee and completed an accredited PGY1 residency program.

Submit the following application materials for the Solid Organ Transplantation Residency to be received by December 31, 2022.

  • Cover letter/Letter of Intent
  • Curriculum Vitae
  • Three (3) formal letter of recommendation
  • Pharmacy college transcripts
  • Application form submitted through PhORCAS application portal by December 31, 2022 deadline

Program Details

Benefits

Current Resident

VUMC Human Resources

Preceptors

Vanderbilt Community

Transplant Resident Graduates

Nashville, Tennessee


Additional Application Information

Number of Positions: One
Residency starting date: July 3, 2023 (tentative)
Estimated stipend - approx. $60,593 *info has not been verified


Contact Information

Rachael Simard, PharmD, BCTXP, Residency Program Director
Nikita Wilson, PharmD, BCPS, DPLA, MMHC, Residency Program Coordinator
Vanderbilt Transplant Center | Vanderbilt Pharmaceutical Services
1211 Medical Center Drive  B-131, VUH | Nashville, TN 37232


Institutional Information

Private non-profit hospital/clinic | Teaching/Tertiary Model | Total Beds 1622
Professional Staff 372 | Non-professional staff 450